Introduction
============

*Candida albicans* is an opportunistic fungal pathogen of humans that can cause human mycoses, ranging from superficial mucosal and skin to invasive candidiasis, especially in immunocompromised patients ([@B9]; [@B21]; [@B13]). In the past two decades, infections caused by *C. albicans* have increased significantly ([@B24]). Invasive candidiasis has an estimated mortality about 40%, even with the use of antifungal drugs ([@B16]; [@B25]). Currently, only a limited number of antifungal agents are being used to treat these infections, including azoles, polyene, and echinocandins drugs. The persistent use of these drugs have caused the emergence of drug-resistant strains. The resistance and shortage of antifungal agents have potentially limited the management of infections. Besides being pathogenic, *C. albicans* also provides an excellent eukaryotic model system to explore the antifungal mechanisms of potent drugs ([@B17]).

Recently, the therapeutic application of antimicrobial peptides (AMPs) or their analogs have received a great deal of attention ([@B5]; [@B19]; [@B27]). AMPs are relatively small (less than 100 amino acid residues), cationic, amphipathic, variable in length, sequence or structure peptides which have been isolated from animals, plants, bacteria, or fungi ([@B37]; [@B28]; [@B44]). AMPs are important components of the innate immunity system against invading pathogens. Many AMPs are effective against multi-drug resistant (MDR) microorganism and less developing resistance due to their distinguished mode of action ([@B42]). Thus, AMPs could be promising candidates for developing novel therapeutic agents against fungi.

*Musca domestica* antifungal peptide-1 (MAF-1), isolated from the instar larvae of housefly, is a kind of a novel cationic AMP with excellent antimicrobial effect ([@B10]). In previous study, full-length of MAF-1 gene was cloned, and bioinformatics analysis was used to explore structure domain and its potential physiological function ([@B26]). MAF-1A peptide was derived from the structure domain of MAF-1 and contained 26 amino acid residues (KKFKETADKLIESAKQQLESLAKEMK). MAF-1A showed its remarkable antifungal effect ([@B26]; [@B55]), but the detailed antifungal actions of MAF-1A remain unclear.

The classic action mechanism of AMPs is cause microbial cell membrane damage. So far, most research has been focused on the use of model membrane systems such as lipid vesicles, to determine the mode of action of AMPs. Even though this knowledge is essential in our understanding of the mode of action of AMPs, it does not fully explain their interaction with microbial cell membrane or the response of microbes to the AMPs ([@B35]). In addition, it has been proposed that some AMPs can interact with intracellular specific targets inducing cell damages, such as the inhibition of DNA, RNA, protein and cell wall synthesis ([@B12]; [@B51]; [@B41]; [@B43]). The analysis of microbial transcriptome may contribute to the understanding of their interaction with novel AMPs ([@B47]). The next generation sequencing technologies for transcriptome analysis have opened the opportunity to understand a wide variety of physiological response of microorganism affected by drugs or environmental conditions treatment. RNA-Seq (deep-sequencing of cDNA) has been used successfully to identify and quantify gene expression at a genome scale level. RNA-Seq shows significant advantages such as sensitive, resolution and comprehensive, and is becoming more popular for various gene expression studies ([@B30]; [@B53]; [@B34]). RNA-Seq enables genome-wide expression studies on the cellular responses and pathways of microbe affected by drug treatment via differential gene expression profiling ([@B14]; [@B38]; [@B20]). This approach has already been used in the cellular responses of *C. albicans* under several different environmental conditions ([@B3]; [@B4]). In the present work, we investigated the differentially expressed genes and the pathways involved using high-throughput RNA-Seq technique to explore the mechanisms of MAF-1A on *C. albicans*.

Materials and Methods {#s1}
=====================

Strain and Growth Conditions
----------------------------

The *C. albicans* ATCC 10231 was used throughout this study. Strain was preserved in nutrient broth supplemented with 30% glycerol stocked and stored at -80°C and streaked on Sabouraud Dextrose agar (SDA) plates (Sangon, Shanghai, China) at 37°C when used.

Peptide Synthesis
-----------------

The synthetic MAF-1A peptide is a linear peptide consisting of a 26 amino acid sequences as follows: KKFKETADKLIESAKQ QLESLAKEMK. Peptides were synthesized by Sangon Biotech Co., Ltd. (Shanghai, China). The purity of peptides was confirmed as higher than 95% using analytical reverse-phase high-performance liquid chromatography (RP-HPLC). Peptides were dissolved in sterilized de-ion water to 10 mg/mL and stored -20°C.

MIC Determinations
------------------

Antifungal activity of MAF-1A was monitored according to Clinical and Laboratory Standards Institute (CLSI) M27-A2. Briefly, the colonies from 24 hour cultures of *C. albicans* were picked and resuspended in 0.9% sterile saline and adjusted to 0.5 Mc Farland standard (1--5 × 10^6^ CFU/mL). The yeast stock suspension was then diluted to obtain a starting inoculum of 0.5 × 10^3^ to 2.5 × 10^3^ CFU/mL. Peptides were then serially diluted in RPMI 1640 medium (Sangon, Shanghai, China) in volume of 100 μL per well, giving final concentrations ranging from 5 mg/mL to 0.1 mg/mL in sterile round bottom 96-well polypropylene microplates. Hundred microliter of standardized yeast suspension was then added to each well. After 24 h of incubation at 37°C, the minimum inhibitory concentration (MIC) was defined as the lowest drug concentration that caused 90% growth inhibition compared to drug-free growth control well by visual evaluation. Amphotericin B (Sigma, United States) and fluconazole (Sigma, United States) were used as controls. The MIC~s~ were determined in triplicate.

Total RNA Extraction
--------------------

The cells of *C. albicans* were inoculated into Sabouraud dextrose broth (SDB) medium (Sangon, Shanghai, China) and cultured at 37°C for 24 h. Before *C. albicans* were harvested for RNA extraction, the cells were treated with MAF-1A at MIC for 2 h (CA_DT). The untreated cultures were used as the control (CA_D). Total RNA was isolated with RNAiso Plus (Takara, Dalian, China) following the manufacturer's instructions. Each RNA sample had an A260: A280 ratio between 1.8 and 2.0. RNA purity was checked using the NanoPhotometer^®^ spectrophotometer (Implen, CA, United States). RNA concentration was measured using Qubit^®^ RNA Assay Kit in Qubit^®^ 2.0 Flurometer (Life Technologies, CA, United States). RNA integrity was assessed using the RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies, CA, United States).

cDNA Library Construction and Illumina RNA-Seq
----------------------------------------------

Libraries construction and RNA-Seq were performed by the Novogene Corporation (Beijing, China). A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using NEBNext^®^ Ultra^TM^ RNA Library Prep Kit for Illumina^®^ (NEB, United States) following manufacturer's recommendations and index codes were added to attribute sequences to each sample. Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Fragmentation was carried out using divalent cations under elevated temperature in NEB Next First Strand Synthesis Reaction Buffer. First strand cDNA was synthesized using random hexamer primer and M-MuLV Reverse Transcriptase (RNase H^-^). Second strand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. Remaining over hangs were converted into blunt ends via exonuclease/polymerase activities. After adenylation of 3′ ends of DNA fragments, NEBNext Adaptor with hairpin loop structure were ligated to prepare for hybridization. In order to select cDNA fragments of preferentially 150∼200 bp in length, the library fragments were purified with AMPure XP system (Beckman Coulter, Beverly, United States). Sequencing library quality was assessed on the Agilent Bioanalyzer 2100 system. Paired-end sequencing of cDNA was carried out with Illumina Hiseq^TM^ 2000. Raw data was filtered by removing reads with adaptor sequences, as well as low quality reads. Then, clean reads were aligned to the reference genome using TopHat v2.0.12. ([@B49]).

Reads Mapping to the Reference Genome
-------------------------------------

Reference genome and gene model annotation files of *C. albicans* SC5314 were downloaded from GenBank (NW_139421). Index of the reference genome was built using Bowtie v2.2.3 and paired-end clean reads were aligned to the reference genome using TopHat v2.0.12. ([@B49]).

Analysis of Differential Expressed Genes
----------------------------------------

The expression level for each gene is determined by the numbers of reads uniquely mapped to the specific gene and the total number of uniquely mapped reads in the sample. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then expected number of Fragments Per Kilobase of transcript sequence per Millions base pairs sequenced (FPKM) of each gene was calculated based on the length of the gene and reads count mapped to this gene ([@B50]).

Differential expression analysis of two conditions was performed using the DEGSeq R package (1.20.0). The *P*-values were adjusted using the Benjamini and Hochberg method. Corrected *P*-value \< 0.005 and log~2~(Fold change) \> 1 were set as the threshold for significantly differential expression ([@B52]).

Enrichment Analysis of Gene Ontology (GO) and KEGG Pathways
-----------------------------------------------------------

Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) was implemented by the GO seq ([@B54]). GO terms with corrected *P*-value \< 0.05 were considered significantly enriched by differential expressed genes. KOBAS 2.0 software was used to test the statistical enrichment of differential expression genes in KEGG pathway ([@B29]). False discovery rate (FDR) of pathways was calculated. The threshold of significance of pathways was set as FDR \< 0.05.

Validation of RNA-Seq by quantitative RT-PCR (qRT-PCR)
------------------------------------------------------

To validate the results of RNA-Seq, eight DEGs (five down-regulated and three up-regulated) were selected for qRT-PCR. According to the SYBR Premix Ex Taq^TM^ Kit (Takara, Dalian, China) protocol, the reactions were run on an ABI7300 real-time PCR system using a 20 μL reaction system with reaction procedures of 40 cycles of 95°C for 5 s and 60°C for 30 s and 72°C for 30 s. Gene expression levels were calculated using the 2^-ΔΔCt^ method ([@B23]) and normalized to the abundance of a house-keeping gene 18S *rRNA*. All samples were examined in triplicate. Target genes using primers listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}.

Results
=======

MIC Assay
---------

The MIC value of the MAF-1A against *C. albicans* was 0.6 mg/mL.

RNA Sequencing and Gene Prediction
----------------------------------

Approximately 50,000,000 raw reads were obtained from each sample. After filtering by quality, 80.30 and 80.01% clean reads from the two groups were mapped to *C. albicans* genome. The profile of transcriptome sequence data was shown in **Table [1](#T1){ref-type="table"}**. Sequence reads have been deposited in the NCBI Sequence Read Archive (SRA) under accession number [PRJNA375109](PRJNA375109)^[1](#fn01){ref-type="fn"}^.

###### 

Profile of the transcriptome sequence data.

  Sample group            CA_D                CA_DT
  ----------------------- ------------------- -------------------
  Raw reads               43101176            51894560
  Clean reads             42085090            50808194
  GC content (%)          37.60               37.09
  Total mapped reads      33794586 (80.30%)   40651013 (80.01%)
  Uniquely mapped reads   33095119 (78.64%)   40001046 (78.73%)
  Multiple mapped reads   699467 (1.66%)      649967 (1.28%)

Transcriptional Stress Response of *C. albicans* to MAF-1A
----------------------------------------------------------

The RNA sequencing results revealed the differences in distribution and density distribution of gene expression between CA_DT and CA_D (**Figure [1](#F1){ref-type="fig"}**). CA_DT was detected 5612 genes expression, CA_D was detected 5546 genes expression. There are 5504 genes co-expression in these two samples, 108 genes were specificity expressed in CA_DT and 42 genes were specificity expressed in CA_D (**Figure [2](#F2){ref-type="fig"}**). The volcano plots of the differentially expressed genes demonstrated that 1032 genes in *C. albicans* were differentially expressed after MAF-1A treatment, with either an increase or decrease of more than twofold (the spots marked in red or green), including 575 up-regulated genes and 457 down-regulated genes (**Figure [3](#F3){ref-type="fig"}**).

![**The comparison diagram of gene expression level. (A)** FPKM (Fragments Per Kilobase of transcript sequence per Millions base pairs sequenced) distribution, **(B)** FPKM density distribution.](fmicb-08-00894-g001){#F1}

![**Gene expression Venn diagram.** The number in each circle represents the total number of genes that are expressed in each sample, and the overlapping part of circles indicates that the gene is co-expressed in both samples.](fmicb-08-00894-g002){#F2}

![**The volcano plots of the differentially expressed genes.** Significantly differentially expressed genes were treated with red dots (up-regulated) or green dots (down-regulated), others indicated with blue dots. The abscissa represents fold change, and the ordinate represents statistical significance.](fmicb-08-00894-g003){#F3}

Verification of Differentially Expressed Genes
----------------------------------------------

To validate the RNA-Seq results, a total of eight genes were selected including five up-regulated and three down-regulated from DGE libraries for qRT-PCR analysis. The results indicated the expression levels have a consistent change for both RNA-Seq and qRT-PCR. Hence, the qRT-PCR results confirmed the reliability of our RNA-Seq data (**Figure [4](#F4){ref-type="fig"}**).

![**Comparison of eight gene expression levels between RNA-Seq and qRT-PCR**.](fmicb-08-00894-g004){#F4}

Analysis of Differential Gene Expression
----------------------------------------

### The Cell Wall Synthesis Related Genes

In this study, two genes involved in the biosynthesis of β-glucan (*KRE1*, *KRE6*) were up-regulated 4.32-fold, 1.31-fold, respectively (**Table [2](#T2){ref-type="table"}**); one gene involved in the biosynthesis of mannoprotein (*MP65)* was up-regulated 5.73-fold (**Table [2](#T2){ref-type="table"}**).

###### 

The genes up-regulated or down-regulated response to MAF-1A.

  Gene name                     Description                                                            log~2~Fold_change   Corrected *P*-value
  ----------------------------- ---------------------------------------------------------------------- ------------------- ---------------------
  **Cell wall synthesis**                                                                                                  
  *KRE1*                        β-1,6-glucan biosynthesis                                              4.32                1.76 × 10^-42^
  *KRE6*                        β-glucan synthesis-associated protein                                  1.31                9.06 × 10^-13^
  *MP65*                        Cell surface mannoprotein                                              5.73                2.77 × 10^-5^
  **Cell membrane synthesis**                                                                                              
  *ERG11*                       Lanosterol 14-alpha demethylase                                        -2.29               8.93 × 10^-30^
  *ERG1*                        Squalene monooxygenase                                                 -1.30               7.30 × 10^-8^
  *ERG5*                        Cytochrome P450 61                                                     -1.90               1.24 × 10^-39^
  *MVD1*                        Diphosphomevalonate decarboxylase                                      -1.01               3.05 × 10^-5^
  *MET6*                        5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase   -1.46               1.63 × 10^-91^
  *FAS1*                        Fatty acid synthase subunit beta                                       -1.66               1.31 × 10^-88^
  *FAS2*                        Fatty acid synthase subunit alpha                                      -2.46               2.39 × 10^-242^
  **Anti oxidative stress**                                                                                                
  *CAT1*                        Peroxisomal catalase                                                   2.63                0.00 × 10^0^
  *SOD1*                        Superoxide dismutase \[Cu-Zn\]                                         1.34                1.07 × 10^-24^
  *SOD4*                        Cell surface superoxide dismutase \[Cu-Zn\] 4                          1.05                3.86 × 10^-6^
  *SOD5*                        Cell surface Cu-only superoxide dismutase 5                            1.91                5.54 × 10^-6^
  *YHB1*                        Flavohemoprotein                                                       3.21                3.30 × 10^-16^
  *AOX2*                        Alternative oxidase 2, mitochondrial                                   1.77                1.22 × 10^-32^

Corrected P-value \< 0.005 were set as the threshold for significantly differential expression.

### The Cell Membrane Synthesis and Stability Related Genes

Several genes involved in ergosterol biosynthesis pathway were down-regulated about twofold (*ERG11, ERG1, ERG5, MET6, MVD1*). Among these genes, *ERG11*expression decreased mostly (**Table [2](#T2){ref-type="table"}**).

*FAS1* and *FAS2* are fatty acid synthesis genes, which are involved in the membrane biosynthesis. After MAF-1A treatment, *FAS1* and *FAS2* were down-regulated 1.66-fold and 2.46-fold, respectively (**Table [2](#T2){ref-type="table"}**).

### Anti Oxidative Stress Genes

In this work, six genes (*CAT1, SOD1, SOD4, SOD5, YHB1, AOX2*) were identified to be up-regulated (1.03-fold to 3.21-fold) in *C. albicans* cells after MAF-1A treatment (**Table [2](#T2){ref-type="table"}**).

### Enrichment Analysis of GO and KEGG Pathways

Gene Ontology and KEGG analysis were used to classify the DEGs in the response of *C. albicans* to MAF-1A. The GO categories significantly enriched (corrected *P*-value \< 0.05) among those DEGs are shown in **Tables [3](#T3){ref-type="table"}**, **[4](#T4){ref-type="table"}**. In the DEGs, a total of 483 up-regulated and 386 down-regulated genes were classified into the following three functional categories: cellular component, molecular function and biological process, respectively. It is noteworthy that within the biological process category of up-regulated DEGs, ribosome, mitochondrion, mitochondrial part, mitochondrial inner membrane, mitochondrial envelope, mitochondrial membrane, mitochondrial membrane part were significantly enriched. The structural constituent of ribosome, oxidoreductase activity terms were enriched in the molecular function category. Oxidation-reduction process, translation terms were enriched in the cellular component category.

###### 

The significant enrich Gene Ontology (GO) terms of up-regulated differentially expressed genes (DEGs).

  Term_type            GO_accession   GO_term                              Corrected *P*-value
  -------------------- -------------- ------------------------------------ ---------------------
  Cellular component   GO:0005840     Ribosome                             1.16 × 10^-6^
                       GO:0044444     Cytoplasmic part                     1.20 × 10^-4^
                       GO:0030529     Ribonucleoprotein complex            1.03 × 10^-3^
                       GO:0005739     Mitochondrion                        3.70 × 10^-3^
                       GO:0044429     Mitochondrial part                   4.00 × 10^-3^
                       GO:0005743     Mitochondrial inner membrane         8.03 × 10^-3^
                       GO:0005740     Mitochondrial envelope               1.12 × 10^-2^
                       GO:0031966     Mitochondrial membrane               2.30 × 10^-2^
                       GO:0019866     Organelle inner membrane             2.30 × 10^-2^
                       GO:0044455     Mitochondrial membrane part          2.78 × 10^-2^
                       GO:0005737     Cytoplasm                            3.11 × 10^-2^
  Molecular function   GO:0003735     Structural constituent of ribosome   1.16 × 10^-6^
                       GO:0016491     Oxidoreductase activity              6.11 × 10^-6^
                       GO:0005198     Structural molecule activity         1.02 × 10^-3^
                       GO:0005215     Transporter activity                 5.19 × 10^-3^
                       GO:0022857     Transmembrane transporter activity   9.31 × 10^-3^
  Biological process   GO:0055114     Oxidation--reduction process         1.83 × 10^-4^
                       GO:0006412     Translation                          4.36 × 10^-3^
                       GO:0055085     Transmembrane transport              4.14 × 10^-2^

Corrected P-value \< 0.05 were set as the threshold for significantly enriched.

###### 

The significant enrich GO terms of down-regulated DEGs.

  Term_type            GO_accession   GO_term                                     Corrected *P*-value
  -------------------- -------------- ------------------------------------------- ---------------------
  Cellular component   GO:0005839     Proteasome core complex                     1.27 × 10^-2^
                       GO:0000502     Proteasome complex                          2.34 × 10^-2^
  Molecular function   GO:0003824     Catalytic activity                          5.27 × 10^-4^
                       GO:0004298     Threonine-type endopeptidase activity       3.02 × 10^-3^
                       GO:0070003     Threonine-type peptidase activity           3.02 × 10^-3^
  Biological process   GO:1901564     Organonitrogen compound metabolic process   7.91 × 10^-3^
                       GO:0008152     Metabolic process                           8.95 × 10^-3^
                       GO:0044281     Small molecule metabolic process            1.76 × 10^-2^
                       GO:0044710     Single-organism metabolic process           1.76 × 10^-2^

Corrected P-value \< 0.05 were set as the threshold for significantly enriched.

By enrichment analysis, up-regulated genes were involved in 11 KEGG metabolic pathways, and down-regulated genes were involved in 1 KEGG metabolic pathway (**Table [5](#T5){ref-type="table"}**). In the mapped pathways of the up-regulated genes, the abundant genes mapped onto ribosome, oxidative phosphorylation, peroxisome, carbon metabolism and citrate cycle (TCA cycle). While, the down-regulated genes were primarily related to proteasome.

###### 

Differentially expressed genes were involved in significant KEGG metabolic pathways.

  Regulated   Term                                           ID         Input number   Background number   Corrected *P*-value
  ----------- ---------------------------------------------- ---------- -------------- ------------------- ---------------------
  Up          Ribosome                                       cal03010   31             140                 3.34 × 10^-5^
              Oxidative phosphorylation                      cal00190   26             129                 6.17 × 10^-4^
              Peroxisome                                     cal04146   18             71                  6.52 × 10^-4^
              Fatty acid degradation                         cal00071   11             32                  2.02 × 10^-3^
              Valine, leucine, and isoleucine degradation    cal00280   9              27                  7.74 × 10^-3^
              Glyoxylate and dicarboxylate metabolism        cal00630   10             34                  7.74 × 10^-3^
              Citrate cycle (TCA cycle)                      cal00020   12             52                  1.24 × 10^-2^
              Carbon metabolism                              cal01200   26             180                 1.63 × 10^-2^
              Alanine, aspartate, and glutamate metabolism   cal00250   10             47                  4.02 × 10^-2^
              Fatty acid metabolism                          cal01212   10             50                  4.80 × 10^-2^
              Propanoate metabolism                          cal00640   6              20                  4.80 × 10^-2^
  Down        Proteasome                                     cal03050   20             63                  2.89 × 10^-4^

Corrected P-value \< 0.05 were set as the threshold for significantly enriched.

Discussion
==========

Antimicrobial peptides are important components of natural defenses against pathogens. The mechanism of antimicrobial activity for these peptides is generally more complex. AMPs were originally proposed to act via plasma membrane permeabilization, leading to membrane rupture and rapid lysis of microbial cells. Recently, it has been proposed that AMP driven microbial death in addition to membrane disruption ([@B33]; [@B36]). In our preliminary work, MAF-1A was shown its remarkable activity anti-*C. albicans*. To further investigate the mechanism of actions of MAF-1A, we used RNA-Seq to study the transcriptomic profile of *C. albicans* treated with MAF-1A. The RNA-Seq results showed that the gene expression of *C. albicans* was extensively altered by MAF-1A treatment. These genes that related to cell wall, plasma membrane and anti-oxidative stress had differentially expressed comparing to control.

The fungal cell wall is essential for sustaining cell morphology and for protection against life threatening environmental conditions ([@B2]; [@B39]). The cell wall of *C. albicans* contains three major macromolecules, including mannoproteins, β-glucan and Chitin ([@B18]). Composition of the cell wall can be quite dynamic, as it changes during cell response to environmental stresses. *C. albicans* constantly remodels the cell wall by breaking and reforming chemical bonds within and between polysaccharides to maintain integrity of the cell wall structure ([@B32]). *C. albicans* could change its expression of cell wall related genes to reduce the toxic effect of caspofungin ([@B22]; [@B31]). In this work, three genes involved in the biosynthesis of cell wall were obviously up-regulated (*KRE1*, *KRE6*, *MP65*) after exposure to MAF-1A. The *KRE1*, *KRE6* encoding proteins are involved in β-glucan biosynthesis, and *MP65* encodes cell surface mannoprotein, which plays a significant role in maintaining cell wall integrity, morphogenesis and pathogenicity ([@B40]). Therefore, the results indicated that these genes may play a role in the mitigation of cell wall damage.

The fungal plasma membrane is similar to those of other eukaryotic cells, composed of a lipid bilayer with proteins embedded within it. Sterols are major components of fungal plasma membranes. The sterol present in animal plasma membranes is cholesterol, while fungi plasma membranes contain ergosterol ([@B48]). This difference in sterol content is exploited in the mechanisms of antifungal agents ([@B45]). Itraconazole, widely used antifungal drugs, belongs to the azoles and interferes with ergosterol biosynthesis. Up-regulation of *ERG* genes were detected in *C. albicans* cells after exposure to Itraconazole *in vitro* ([@B7]). On the contrary, *in vitro* exposure of *C. albicans* to amphotericin B (AMB) is correlated with under-expression of *ERG* genes ([@B22]). Binding to ergosterol is sufficient for antifungal activity of AMB and therefore considered the primary mode of fungicidal action ([@B11]). Besides, AMPs could kill the target cells by disrupting the integrity of fungal membranes ([@B1]). In the current study, several genes (*ERG11, ERG1, ERG5, MET6, MVD1*) involved in ergosterol biosynthesis pathway were under-expression. The results indicated that MAF-1A could interfere with ergosterol biosynthesis. We speculate that down-regulation of certain ergosterol biosynthesis genes may reduce the binding of MAF-1A to ergosterol. In addition, *FAS1* and *FAS2* involved in fatty acid biosynthesis were down-regulated, indicating the composition in cell membrane was also affected by the presence of MAF-1A.

ROS, such as hydrogen peroxide and hydroxyl radicals, cause damage to proteins, lipids and nucleic acids, resulting in irreversible damage and loss of viability. A well-characterized response of eukaryotic microbes to ROS is the rapid induction of mRNAs that encode oxidative stress detoxification and repair proteins. These include catalase (*CAT1*), glutathione peroxidase (*GPX*) and superoxide dismutase (*SOD*) antioxidant-encoding genes ([@B6]). Various antifungal agents have been confirmed to cause oxidative damage to *C. albicans* ([@B8]). For example, a number of genes involved in oxidative stress response (*YHB1, CTA1, AOX1*, *and SOD2*) were found to be up-regulated upon AMB treatment ([@B22]). In this research, such oxidative stress-responsive genes in *C. albicans* are also up-regulated following exposure to MAF-1A. These genes included *CAT1, SOD1, SOD4, SOD5, AOX2*, and *YHB1*, encodes catalase, superoxide dismutase, alternative oxidases and flavohemoprotein, respectively.

The significantly enriched GO term in the cellular component category suggest that nearly all cellular components were affected including the ribosomes, mitochondrion, cytoplasm, and organelle inner membrane. The significant enrichment of GO terms associated with molecular function indicates that the transcription levels of structural constituent of ribosome, oxidoreductase, structural molecule activity, transmembrane transporter genes were significantly changed. In addition, KEGG analysis showed that twelve metabolic pathways were affected in *C. albicans* upon MAF-1A treatment. Three metabolic pathways, including "ribosome", "oxidative phosphorylation", and "citrate cycle", are the metabolic pathways of protein biosynthesis, cellular respiration and ATP generation.

It is widely accepted that membrane interaction is a key factor for antimicrobial activity of AMPs. Furthermore, AMPs can also act up on multiple cell targets, involving a mixed multi-hit mechanism ([@B12]; [@B51]; [@B44]; [@B43]). Considering the changes of expression pattern, it is strongly suggested that *C. albicans* inhibition caused by MAF-1A should be a result of multiple and complementary actions, involving in cell wall, plasma membrane, as well as protein synthesis and energy metabolism (**Figure [5](#F5){ref-type="fig"}**). It should be noted that this study has examined only on transcriptional level and further experiments are required to determine the *anti-C*. *albicans* key mechanisms.

![**Schematic overview of the proposed mechanisms of action of MAF-1A**.](fmicb-08-00894-g005){#F5}

Conclusion
==========

We analyzed the gene expression changes for *C. albicans* under treatment of MAF-1A using RNA-seq. The results from this study suggest that MAF-1A induces complex responses in *C. albicans* and MAF-1A has the potential to inhibit *C. albicans* growth through affect multi-targets of *C. albicans* cells. This study provides important insights into the mechanisms of action of MAF-1A and the responds of *C. albicans* under AMPs stress. However, further studies are needed to determine the key mechanisms that *C. albicans* responses to MAF-1A.
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